TTRXTurn Therapeutics Inc.
$6.82
$6.82
$2.7152 weeks$15.28
Price
End-of-day closes, not the intraday tick.
The five questions
2 of 5 availableOnly two of the five can be answered for TTRX today. The rest need figures this filer has not published. The tabs above still show whatever data does exist.
- Is the business good?not enough filed
- Is it safe?Mixed
- Is the price fair?not enough filed
- Is it growing?not enough filed
- What is the market doing?Good
P/En/a
Market value$341.4M
1 yearn/a
5 yearsn/a
Charts
As reported to the SEC, without any scoring.
The next results filing is expected around Nov 12, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Oct 7, 2026Corporate Presentation October 2026.Regulation FD disclosure · press release
- Sep 10, 2026Turn Therapeutics to Present at Stifel 2026.Regulation FD disclosure · press release
- Sep 9, 2026Turn Therapeutics Appoints Former CDC Director.Regulation FD disclosure · press release
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Biotechnology
The closest names by size in the same industry